Holdings (as at 2026-06-18)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Humana Inc. 4.51%
Organon & Co. 3.89%
DaVita Inc. 2.94%
Elevance Health Inc. 2.88%
Exelixis, Inc. 2.63%
Molina Healthcare, Inc. 2.54%
Solventum Corporation 2.51%
Biogen Inc. 2.33%
Cardinal Health, Inc. 2.28%
The Cigna Group 2.27%
Incyte Corporation 2.26%
Bio-Rad Laboratories, Inc. (Class A) 2.20%
Zimmer Biomet Holdings, Inc. 2.11%
Chemed Corporation 2.00%
Globus Medical, Inc. (Class A) 2.00%
Encompass Health Corporation 1.76%
HCA Healthcare, Inc. 1.72%
Universal Health Services, Inc. (Class B) 1.71%
Regeneron Pharmaceuticals, Inc. 1.71%
Illumina, Inc. 1.71%
Ionis Pharmaceuticals, Inc. 1.71%
Penumbra, Inc. 1.68%
Amgen Inc. 1.66%
Merck & Co., Inc. 1.64%
QIAGEN N.V. 1.60%
Becton, Dickinson and Company 1.59%
Tenet Healthcare Corporation 1.59%
United Therapeutics Corporation 1.57%
Pfizer Inc. 1.56%
Natera, Inc. 1.51%
Revvity, Inc. 1.48%
Henry Schein, Inc. 1.41%
Quest Diagnostics Incorporated 1.30%
UnitedHealth Group Incorporated 1.29%
Certara, Inc. 1.27%
Labcorp Holdings Inc. 1.25%
The Cooper Companies, Inc. 1.20%
Medtronic Plc 1.19%
Steris Plc 1.19%
Bristol-Myers Squibb Company 1.16%
Gilead Sciences, Inc. 1.16%
GE HealthCare Technologies Inc. 1.13%
ResMed Inc. 1.09%
Sarepta Therapeutics, Inc. 1.05%
Neurocrine Biosciences, Inc. 1.04%
Eli Lilly and Company 1.03%
Waters Corporation 1.03%
Insmed Incorporated 1.02%
Agilent Technologies, Inc. 0.97%
Align Technology, Inc. 0.92%
Halozyme Therapeutics, Inc. 0.92%
IQVIA Holdings Inc. 0.85%
BioMarin Pharmaceutical Inc. 0.84%
Medpace Holdings, Inc. 0.84%
Thermo Fisher Scientific Inc. 0.82%
Johnson & Johnson 0.81%
Abbott Laboratories 0.75%
Medline Inc. (Class A) 0.70%
Zoetis Inc. 0.58%
West Pharmaceutical Services, Inc. 0.53%
DexCom, Inc. 0.47%
Royalty Pharma Plc (Class A) 0.45%
Sotera Health Company 0.45%
Edwards Lifesciences Corporation 0.44%
Envista Holdings Corporation 0.42%
Vertex Pharmaceuticals Incorporated 0.41%
IDEXX Laboratories, Inc. 0.41%
AbbVie Inc. 0.41%
Danaher Corporation 0.38%
Stryker Corporation 0.38%
Viking Therapeutics, Inc. 0.38%
Intuitive Surgical, Inc. 0.36%
Veeva Systems Inc. (Class A) 0.35%
Alnylam Pharmaceuticals, Inc. 0.34%
Boston Scientific Corporation 0.29%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.